Drug
nirsevimab
Marketed as BEYFORTUS.
Generic name
nirsevimab
Brand names
BEYFORTUS
First FDA approval
2023-07-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761328 | BEYFORTUS | 2023-07-17 | ASTRAZENECA AB |
Manufacturers
ASTRAZENECA AB
Frequently asked questions
When was nirsevimab FDA approved?
Earliest FDA approval on record: 2023-07-17.
What brand names are sold as nirsevimab?
BEYFORTUS.
Sources
Appeal a nirsevimab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com